Market Cap 2.64B
Revenue (ttm) 5.81B
Net Income (ttm) -386.00M
EPS (ttm) N/A
PE Ratio 18.30
Forward PE 13.51
Profit Margin -6.65%
Debt to Equity Ratio 16.50
Volume 4,146,300
Avg Vol 3,517,576
Day's Range N/A - N/A
Shares Out 150.11M
Stochastic %K 72%
Beta 1.60
Analysts Sell
Price Target $19.33

Company Profile

The Chemours Company provides performance chemicals in North America, the Asia Pacific, Europe, the Middle East, Africa, and Latin America. The company operates through three segments: Thermal & Specialized Solutions, Titanium Technologies, and Advanced Performance Materials. The Thermal & Specialized Solutions segment provides refrigerants, thermal management solutions, propellants, foam blowing agents, and specialty solvents under the Freon and Opteon brand names. The Titanium Technologies seg...

Industry: Specialty Chemicals
Sector: Basic Materials
Phone: 302 773 1000
Address:
1007 Market Street, P.O. Box 2047, Wilmington, United States
OnlyFibs
OnlyFibs Mar. 14 at 6:54 PM
$CC Unusal Calls
0 · Reply
AlgoMason
AlgoMason Mar. 14 at 5:52 AM
$CC chemical manufacturing company Chemours
0 · Reply
erevnon
erevnon Mar. 5 at 3:19 PM
Mizuho maintains Chemours $CC at Outperform and raises the price target from $17 to https://marketsblock.com/stock-upgrades-and-downgrades/
0 · Reply
johnwatson2
johnwatson2 Mar. 3 at 1:58 PM
$CC yes! very normal for a chemical company to gap down 4% on no company-related news! fun
0 · Reply
ZacksResearch
ZacksResearch Mar. 2 at 2:01 PM
$CC just made a bold capital move 💰 The company priced $700M of 7.875% senior notes due 2034 — upsizing the deal to refinance 2027 and 2028 debt and reshape its debt profile. That’s a clear signal they’re actively managing maturities and locking in long-term financing. Smart balance sheet strategy or expensive money? See what this means for the stock 👉 https://www.zacks.com/stock/news/2877305/chemours-upsizes-and-prices-700-million-senior-notes-offering?cid=sm-stocktwits-2-2877305-teaser-35698&ADID=SYND_STOCKTWITS_TWEET_2_2877305_TEASER_35698
0 · Reply
ZacksResearch
ZacksResearch Mar. 2 at 1:01 PM
$CC priced $700M in senior notes — what’s the strategy? 🧐 🔗 Proceeds to redeem 2027 notes & partially redeem 2028 notes, aiming to enhance debt profile. 📈 Stock climbed 31.6% over the past year, outpacing the industry’s 9.8% decline. ⚠️ Currently holds a Zacks Rank #4 (Sell). https://www.zacks.com/stock/news/2877305/chemours-upsizes-and-prices-700-million-senior-notes-offering?cid=sm-stocktwits-2-2877305-body-35696&ADID=SYND_STOCKTWITS_TWEET_2_2877305_BODY_35696
0 · Reply
erevnon
erevnon Feb. 25 at 6:11 PM
Goldman Sachs maintains Chemours $CC at Neutral and raises the price target from $14 to https://marketsblock.com/stock-upgrades-and-downgrades/
0 · Reply
JHR
JHR Feb. 25 at 3:43 PM
$CC I'm fully allocated here now 💪
0 · Reply
erevnon
erevnon Feb. 23 at 9:06 PM
UBS maintains Chemours $CC at Buy and raises the price target from $18 to https://marketsblock.com/stock-upgrades-and-downgrades/
0 · Reply
ALRAE
ALRAE Feb. 23 at 7:05 PM
$CC 50+
0 · Reply
Latest News on CC
The Chemours Company (CC) Q4 2025 Earnings Call Transcript

Feb 20, 2026, 12:15 PM EST - 23 days ago

The Chemours Company (CC) Q4 2025 Earnings Call Transcript


Chemours Announces First Quarter Dividend

Feb 17, 2026, 4:30 PM EST - 25 days ago

Chemours Announces First Quarter Dividend


Chemours: Upside More Confirmed In 2026E

Jan 29, 2026, 2:22 AM EST - 6 weeks ago

Chemours: Upside More Confirmed In 2026E


Chemours: Solid Momentum Despite One-Time Costs In Q3

Nov 11, 2025, 11:14 AM EST - 4 months ago

Chemours: Solid Momentum Despite One-Time Costs In Q3


The Chemours Company (CC) Q3 2025 Earnings Call Transcript

Nov 7, 2025, 11:46 AM EST - 4 months ago

The Chemours Company (CC) Q3 2025 Earnings Call Transcript


Chemours Stock Drops. Here's Why.

Nov 7, 2025, 11:33 AM EST - 4 months ago

Chemours Stock Drops. Here's Why.


The Chemours Company Reports Third Quarter 2025 Results

Nov 6, 2025, 4:30 PM EST - 4 months ago

The Chemours Company Reports Third Quarter 2025 Results


Chemours Announces Fourth Quarter Dividend

Oct 29, 2025, 5:00 PM EDT - 4 months ago

Chemours Announces Fourth Quarter Dividend


Chemours: Getting In Before The Upside And Before Q3

Oct 28, 2025, 5:54 PM EDT - 4 months ago

Chemours: Getting In Before The Upside And Before Q3


The Chemours Company (CC) Q2 2025 Earnings Call Transcript

Aug 6, 2025, 10:19 AM EDT - 7 months ago

The Chemours Company (CC) Q2 2025 Earnings Call Transcript


The Chemours Company Reports Second Quarter 2025 Results

Aug 5, 2025, 4:56 PM EDT - 7 months ago

The Chemours Company Reports Second Quarter 2025 Results


Chemours Guides for 2Q Sales at High End of Prior Forecast

Jun 18, 2025, 7:10 AM EDT - 9 months ago

Chemours Guides for 2Q Sales at High End of Prior Forecast


Chemours Appoints Matthew Conti as Chief Human Resources Officer

Jun 12, 2025, 4:30 PM EDT - 9 months ago

Chemours Appoints Matthew Conti as Chief Human Resources Officer


The Chemours Company (CC) Q1 2025 Earnings Call Transcript

May 7, 2025, 2:05 PM EDT - 11 months ago

The Chemours Company (CC) Q1 2025 Earnings Call Transcript


Chemours: Dividend Cut May Signal A Bottom Is Near

May 6, 2025, 11:41 PM EDT - 11 months ago

Chemours: Dividend Cut May Signal A Bottom Is Near


The Chemours Company Reports First Quarter 2025 Results

May 6, 2025, 4:30 PM EDT - 11 months ago

The Chemours Company Reports First Quarter 2025 Results


The Long-Term Upside For Chemours Company After Q4 2024

Feb 19, 2025, 7:01 AM EST - 1 year ago

The Long-Term Upside For Chemours Company After Q4 2024


OnlyFibs
OnlyFibs Mar. 14 at 6:54 PM
$CC Unusal Calls
0 · Reply
AlgoMason
AlgoMason Mar. 14 at 5:52 AM
$CC chemical manufacturing company Chemours
0 · Reply
erevnon
erevnon Mar. 5 at 3:19 PM
Mizuho maintains Chemours $CC at Outperform and raises the price target from $17 to https://marketsblock.com/stock-upgrades-and-downgrades/
0 · Reply
johnwatson2
johnwatson2 Mar. 3 at 1:58 PM
$CC yes! very normal for a chemical company to gap down 4% on no company-related news! fun
0 · Reply
ZacksResearch
ZacksResearch Mar. 2 at 2:01 PM
$CC just made a bold capital move 💰 The company priced $700M of 7.875% senior notes due 2034 — upsizing the deal to refinance 2027 and 2028 debt and reshape its debt profile. That’s a clear signal they’re actively managing maturities and locking in long-term financing. Smart balance sheet strategy or expensive money? See what this means for the stock 👉 https://www.zacks.com/stock/news/2877305/chemours-upsizes-and-prices-700-million-senior-notes-offering?cid=sm-stocktwits-2-2877305-teaser-35698&ADID=SYND_STOCKTWITS_TWEET_2_2877305_TEASER_35698
0 · Reply
ZacksResearch
ZacksResearch Mar. 2 at 1:01 PM
$CC priced $700M in senior notes — what’s the strategy? 🧐 🔗 Proceeds to redeem 2027 notes & partially redeem 2028 notes, aiming to enhance debt profile. 📈 Stock climbed 31.6% over the past year, outpacing the industry’s 9.8% decline. ⚠️ Currently holds a Zacks Rank #4 (Sell). https://www.zacks.com/stock/news/2877305/chemours-upsizes-and-prices-700-million-senior-notes-offering?cid=sm-stocktwits-2-2877305-body-35696&ADID=SYND_STOCKTWITS_TWEET_2_2877305_BODY_35696
0 · Reply
erevnon
erevnon Feb. 25 at 6:11 PM
Goldman Sachs maintains Chemours $CC at Neutral and raises the price target from $14 to https://marketsblock.com/stock-upgrades-and-downgrades/
0 · Reply
JHR
JHR Feb. 25 at 3:43 PM
$CC I'm fully allocated here now 💪
0 · Reply
erevnon
erevnon Feb. 23 at 9:06 PM
UBS maintains Chemours $CC at Buy and raises the price target from $18 to https://marketsblock.com/stock-upgrades-and-downgrades/
0 · Reply
ALRAE
ALRAE Feb. 23 at 7:05 PM
$CC 50+
0 · Reply
koditrump
koditrump Feb. 23 at 6:36 PM
0 · Reply
erevnon
erevnon Feb. 23 at 6:12 PM
Morgan Stanley maintains Chemours $CC at Equal-Weight and raises the price target from $15 to https://marketsblock.com/stock-upgrades-and-downgrades/
0 · Reply
ZacksResearch
ZacksResearch Feb. 23 at 6:03 PM
$CC beats on earnings — but the headline loss just widened year over year. So what’s really going on? Q4 sales dipped 2% and the company posted a wider y/y loss, yet the bottom line still topped estimates as Thermal & Specialized Solutions surged on strong refrigerant pricing. That segment strength is doing some heavy lifting. 🔥 Is this early stabilization or just a temporary boost from pricing? Get the full picture 👉 https://www.zacks.com/stock/news/2873782/chemours-q4-earnings-surpass-estimates-revenues-in-line?cid=sm-stocktwits-2-2873782-teaser-34756&ADID=SYND_STOCKTWITS_TWEET_2_2873782_TEASER_34756
0 · Reply
ZacksResearch
ZacksResearch Feb. 23 at 5:03 PM
$CC posts a bigger Q4 loss, but beats earnings estimates 📉 🔹 Net loss widened to 31 cents per share, but earnings per share excluding one-time items beat the Zacks Consensus Estimate. 🔹 Sales dipped 2.2%, in line with expectations. The Titanium Technologies division saw an 11% revenue decline. 🔹 Thermal & Specialized Solutions shone with a 14% revenue jump, driven by strong demand for Opteon refrigerants. See why CC carries a Zacks Rank #4 (Sell) and what it means for investors 👉 https://www.zacks.com/stock/news/2873782/chemours-q4-earnings-surpass-estimates-revenues-in-line?cid=sm-stocktwits-2-2873782-body-34735&ADID=SYND_STOCKTWITS_TWEET_2_2873782_BODY_34735
0 · Reply
MelanieStiegman869
MelanieStiegman869 Feb. 21 at 7:28 AM
$CC Chemours manufactures specialty chemicals. Earnings depend on industrial demand. Environmental liabilities remain a risk.
0 · Reply
ALRAE
ALRAE Feb. 20 at 9:13 PM
$CC I feel sorry for anyone who shorted this today. $50+
0 · Reply
lozzamozza
lozzamozza Feb. 20 at 6:36 PM
1 · Reply
JHR
JHR Feb. 20 at 4:16 PM
$CC I do like this. Maybe I nibble a bit here and see what happens
0 · Reply
ALRAE
ALRAE Feb. 20 at 4:12 PM
$CC 50+ .....
1 · Reply
koditrump
koditrump Feb. 20 at 3:55 PM
0 · Reply
lozzamozza
lozzamozza Feb. 20 at 2:59 PM
0 · Reply
Recon2023
Recon2023 Feb. 20 at 3:40 AM
$CC 5.92 dividend accuarate
0 · Reply